Showing results (291-300 of 724) with videos related to
Sort By:
Pageof 73
Cancer|April 1, 1993
Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. The National Biotherapy Study Group experienceR O Dillman, C Church, R K Oldham, et al.Global Change Biology|December 25, 2014
Experimental climate warming alters aspen and birch phytochemistry and performance traits for an outbreak insect herbivoreMary A Jamieson, Ezra G Schwartzberg, Kenneth F Raffa, et al.The Journal of Community and Supportive Oncology|April 2, 2015
Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysisGary R Morrow, Lee Schwartzberg, Sally Y Barbour, et al.Pediatric Surgery International|June 6, 2019
Transabdominal re-do pouch surgery in pediatric patients for failed ileal pouch anal anastomosis: a case matched studyErman Aytac, Eren Esen, H Hande Aydinli, et al.Journal of Cancer Survivorship : Research and Practice|March 2, 2018
Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trialIlana Graetz, Caitlin N McKillop, Edward Stepanski, et al.Nano Letters|April 6, 2010
Direct chemical vapor deposition of graphene on dielectric surfacesAriel Ismach, Clara Druzgalski, Samuel Penwell, et al.Clinical Breast Cancer|July 25, 2008
Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancerCraig Bunnell, Linda Vahdat, Lee Schwartzberg, et al.Bone Marrow Transplantation|May 1, 1993
Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapyL Schwartzberg, R Birch, R Blanco, et al.Clinical Breast Cancer|July 16, 2014
Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancerSharon Wilks, Shannon Puhalla, Joyce O'Shaughnessy, et al.Nature|June 29, 2022
Scalable single-mode surface-emitting laser via open-Dirac singularitiesRushin Contractor, Wanwoo Noh, Walid Redjem, et al.Pageof 73